American Century Companies Inc Alkermes Plc. Transaction History

American Century Companies Inc

$188 Billion
Q3 2025

A detailed history of American Century Companies Inc transactions in Alkermes Plc. stock. As of the latest transaction made, American Century Companies Inc holds 4,397,471 shares of ALKS stock, worth $128 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

4,397,471

Previous 3,657,223 20.24%

Holding current value

$128 Million

Previous $105 Million 26.08%

% of portfolio

0.07%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$26.13 - $30.46 $19.3 Million - $22.5 Million	740,248 Added 20.24%	4,397,471 $132 Million
Q2 2025 Aug 12, 2025	BUY	$26.59 - $32.65 $5.09 Million - $6.25 Million	191,549 Added 5.53%	3,657,223 $105 Million
Q1 2025 May 13, 2025	BUY	$28.08 - $36.0 $420,273 - $538,812	14,967 Added 0.43%	3,465,674 $114 Million
Q4 2024 Feb 11, 2025	BUY	$25.7 - $31.46 $5.39 Million - $6.6 Million	209,740 Added 6.47%	3,450,707 $99.2 Million
Q3 2024 Nov 12, 2024	BUY	$23.01 - $28.55 $23.9 Million - $29.6 Million	1,037,511 Added 47.09%	3,240,967 $90.7 Million

Q2 2024 Aug 07, 2024	BUY	$23.21 - $27.24 $23.8 Million - $27.9 Million	1,025,905 Added 87.12%	2,203,456 $53.1 Million
Q1 2024 May 14, 2024	BUY	$26.4 - $32.56 $3.35 Million - $4.14 Million	127,077 Added 12.1%	1,177,551 $31.9 Million
Q4 2023 Feb 13, 2024	BUY	$23.37 - $28.68 $24.5 Million - $30.1 Million	1,050,474 New	1,050,474 $29.1 Million
Q3 2023 Nov 13, 2023	BUY	$27.17 - $31.97 $6.23 Million - $7.33 Million	229,181 Added 35.31%	878,272 $24.6 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $17.8 Million - $21.1 Million	627,548 Added 2913.0%	649,091 $20.3 Million
Q1 2023 May 11, 2023	BUY	$25.31 - $29.02 $125,486 - $143,881	4,958 Added 29.89%	21,543 $607,000
Q4 2022 Feb 13, 2023	SELL	$21.94 - $26.24 $1.24 Million - $1.48 Million	-56,539 Reduced 77.32%	16,585 $433,000
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $884,048 - $1.28 Million	40,184 Added 121.99%	73,124 $1.63 Million
Q2 2022 Aug 12, 2022	BUY	$26.4 - $30.54 $38,966 - $45,077	1,476 Added 4.69%	32,940 $981,000
Q1 2022 May 11, 2022	SELL	$23.07 - $27.99 $317,789 - $385,562	-13,775 Reduced 30.45%	31,464 $828,000
Q4 2021 Feb 07, 2022	BUY	$21.47 - $32.08 $41,716 - $62,331	1,943 Added 4.49%	45,239 $1.05 Million
Q3 2021 Nov 10, 2021	BUY	$23.37 - $32.13 $1.01 Million - $1.39 Million	43,296 New	43,296 $1.34 Million

Others Institutions Holding ALKS

# of Institutions

401

Shares Held

176M

Call Options Held

901K

Put Options Held

400K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.77B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Alkermes Plc. Transaction History